Healthcare - Biotechnology - NYSE - US
$ 2.63
-8.36 %
$ 885 M
Market Cap
-1.21
P/E
BALANCE SHEET
621 M
ASSETS
16.4 M
LIABILITIES
605 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Nuvation Bio Inc.
| Current Assets | 616 M |
| Cash & Short-Term Investments | 611 M |
| Receivables | 3.7 M |
| Other Current Assets | 1.52 M |
| Non-Current Assets | 5.05 M |
| Long-Term Investments | 0 |
| PP&E | 4.32 M |
| Other Non-Current Assets | 728 K |
| Current Liabilities | 14 M |
| Accounts Payable | 2.21 M |
| Short-Term Debt | 3.94 M |
| Other Current Liabilities | 7.82 M |
| Non-Current Liabilities | 2.39 M |
| Long-Term Debt | 2.04 M |
| Other Non-Current Liabilities | 353 K |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 42.6 | 101.1 | 132.4 | 29.8 | 3.5 | 0.1 |
| Short Term Investments | 568.6 | 559.9 | 633.0 | 186.0 | 115.4 | 0 |
| Receivables | 3.7 | 2.5 | 3.0 | 1.1 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 2.9 | 0 | 0 |
| Other Current Assets | 1.5 | 3.8 | 3.6 | 3.8 | 1.0 | 20 K |
| Total Current Assets | 616.4 | 667.3 | 772.1 | 220.7 | 119.9 | 0.2 |
| PP&E | 4.3 | 4.7 | 3.7 | 0.7 | 0.6 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | (559.4) | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 0.7 | 559.5 | 0.4 | 0.4 | 0.4 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 621.5 | 672.1 | 776.2 | 221.8 | 121.0 | 0.2 |
| LIABILITIES | ||||||
| Accounts Payable | 2.2 | 2.1 | 3.9 | 2.2 | 2.0 | 83 K |
| Short Term Debt | 3.9 | 2.4 | 1.7 | 0 | 0 | 0.6 |
| Other Current Liabilities | 7.7 | 8.5 | 10.9 | 4.4 | 1.2 | 0.2 |
| Total Current Liabilities | 14.0 | 13.2 | 16.9 | 6.6 | 3.2 | 0.9 |
| Long Term Debt | 2.0 | 3.1 | 2.2 | 0 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.4 | 0.8 | 11.0 | 0.2 | 0 | 0 |
| Total Liabilities | 16.4 | 17.1 | 30.2 | 6.7 | 3.2 | 0.9 |
| EQUITY | ||||||
| Common Stock | 947.7 | 927.6 | 910.0 | 289.5 | 9.8 | 0 |
| Retained Earnings | (342.8) | (267.0) | (162.8) | (76.0) | (34.3) | (0.7) |
| Other Accumulative Comprehensive Income/Loss | 0.2 | (5.5) | (1.2) | 1.6 | 0.4 | 0 |
| Total Equity | 605.1 | 655.1 | 746.0 | 215.1 | 117.7 | (0.7) |
| Total Liabilities and Equity | 621.5 | 672.1 | 776.2 | 221.8 | 121.0 | 0.2 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 218.9 | 216.7 | 197.9 | 97.5 | 206.7 | 81.0 |